SEC Form 4 · accession 0001209191-17-040121
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas J Seith
Officer — Chief Operating Officer
Period of report
Jun 13, 2017
Accepted (ET)
Jun 15, 2017 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2017 | M | 1,500 | $10.10 | A | 240,979 | D | |
| Common Stock | Jun 13, 2017 | M | 10,000 | $10.05 | A | 250,979 | D | |
| Common Stock | Jun 13, 2017 | M | 512 | $5.70 | A | 251,491 | D | |
| Common Stock | Jun 13, 2017 | M | 21,100 | $6.27 | A | 272,591 | D | |
| Common Stock | Jun 13, 2017 | M | 25,000 | $6.73 | A | 297,591 | D | |
| Common StockF1 | Jun 13, 2017 | S | 58,112 | $21.39 | D | 239,479 | D | |
| Common StockF2 | holding | — | — | — | 3,500 | I | Held by spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $10.10 | Jun 13, 2017 | M | 1,500 | D | May 28, 2009 | May 28, 2018 | Common Stock | 1,500 | 0 | D |
| Stock Option (right to buy)F4 | $10.05 | Jun 13, 2017 | M | 10,000 | D | Jul 30, 2009 | Jul 30, 2018 | Common Stock | 10,000 | 0 | D |
| Stock Option (right to buy)F5 | $5.70 | Jun 13, 2017 | M | 512 | D | Oct 28, 2009 | Oct 28, 2018 | Common Stock | 512 | 0 | D |
| Stock Option (right to buy)F6 | $6.27 | Jun 13, 2017 | M | 21,100 | D | Oct 25, 2013 | Oct 25, 2022 | Common Stock | 21,100 | 0 | D |
| Stock Option (right to buy)F7 | $6.73 | Jun 13, 2017 | M | 25,000 | D | Dec 27, 2013 | Dec 27, 2022 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $21.08 to $21.65 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
- F3These options were granted on May 28, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
- F4These options were granted on July 30, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
- F5These options were granted on October 28, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
- F6These options were granted on October 25, 2012 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
- F7These options were granted on December 27, 2012 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.